SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-008529
Filing Date
2020-03-16
Accepted
2020-03-16 20:31:02
Documents
1
Period of Report
2020-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4167
  Complete submission text file 0000899243-20-008529.txt   5443
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 129 ELSIE STREET SAN FRANCISCO CA 94110
Business Address
Doberstein Stephen K (Reporting) CIK: 0001480111 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 20718972